CN107375426A - A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils - Google Patents
A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils Download PDFInfo
- Publication number
- CN107375426A CN107375426A CN201610319192.1A CN201610319192A CN107375426A CN 107375426 A CN107375426 A CN 107375426A CN 201610319192 A CN201610319192 A CN 201610319192A CN 107375426 A CN107375426 A CN 107375426A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- essential oils
- moxibustion
- large intestine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of moxibustion lung large intestine system channels and network vessels regulation essential oils, it is made up of the component of following parts by weight：4 10 parts of Chinese mugwort oil, 15 parts of cinnamon oil, 15 parts of patchouli oil, 15 parts of evening primrose oil.Beneficial effects of the present invention ensure smooth breathing to moisten the lung and relieve the cough；Gut purge defaecation, excretion vivotoxin etc..
Description
Technical field
The invention belongs to tcm health preserving field, more particularly to a kind of essential oils for nursing one's health human body moxibustion lung large intestine system channels and collaterals.
Background technology
The heart.Essential oils are widely used in health field, and application method is varied, can be with stacte method, inhalation, aromatic bath method and massage etc..Consumer feels salubrious comfortable, complete non-greasy when using essential oils.
In the prior art, essential oils are widely used in whitening spot-removing, skin-protecting face nursing, but it is fewer with the essential oils of lung large intestine system channels and collaterals to nurse one's health human body moxibustion；And the problems such as derived essential oil species is excessive in formula be present.
The content of the invention
In view of this, the invention provides a kind of moxibustion lung large intestine system channels and network vessels regulation essential oils.In order to which some aspects of the embodiment to disclosure have a basic understanding, simple summary shown below is.
The technical scheme is that：
A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils, are made up of the component of following parts by weight：End oily 4-10 parts, cinnamon oil 1-5 parts, patchouli oil 1-5 parts, evening primrose oil 1-5 parts.
In some optional embodiments, moxibustion lung large intestine system channels and network vessels regulation essential oils, it is made up of the component of following parts by weight：End oily 5-9 parts, cinnamon oil 2-4 parts, patchouli oil 2-4 parts, evening primrose oil 2-4 parts.
In some optional embodiments, moxibustion lung large intestine system channels and network vessels regulation essential oils, it is made up of the component of following parts by weight：5 parts of Chinese mugwort oil, 3 parts of cinnamon oil, 3 parts of patchouli oil, 3 parts of evening primrose oil.
Beneficial effects of the present invention：With moistening the lung and relieve the cough, smooth breathing is ensured；Gut purge defaecation, excretion vivotoxin and other effects.
In technical solution of the present invention, effect is as follows the effect of various raw material essential oils：
Folium artemisiae argyi, it is bitter, pungent, it is warm-natured.Return liver, spleen, kidney channel.Bitter dry pungent scattered, traditional property theory thinks that folium artemisiae argyi has rationale blood, by cold-dampness, only warm meridians, the effect such as crymodynia, hemostasis, antiabortive.Modern experimental research has shown that folium artemisiae argyi has antibacterial and antivirus action;Relieving asthma, antibechic and phlegm-dispelling functions;Hemostasis and blood coagulation resisting function;Calm and anti-allergic effects;Protect liver choleretic effect etc..For spitting blood, bleeding from five sense organs or subcutaneous tissue, uterine bleeding, menorrhalgia, blood under threatened abortion, few abdomen crymodynia, through uncomfortable, uterus cold infertile of trembling with fear；Control pruitus outside.Vinegar Chinese mugwort charcoal warming channel for arresting bleeding, for deficient cold type bleeding.The oil that ends is its extract.
Chinese cassia tree is also known as male osmanthus, purple osmanthus, great Gui.Acrid flavour, sweet, extremely hot in nature.Return kidney, spleen, the heart, Liver Channel.There is a mends fire supporing yang, guiding fire to origin, eliminating cold to stop pain, the effect of warming meridian.For impotence Gong Leng, waist and knee crymodynia, deficiency of the kidney and dyspnea, deficient yang with upper manifestation, dizziness hot eyes, trusted subordinate's crymodynia, cold of insufficiency type vomiting and diarrhea, cold hernia stomachache, dysmenorrhoea Amenorrhea.Cinnamon oil is its extract.
Pogostemon cablin is also known as great Ye peppermints, mountain fennel, common clearweed herb.Acrid flavour, slightly warm in nature.Returns spleen, stomach, lung channel.With eliminating dampness with aromatics, and middle preventing or arresting vomiting, deliver relieving summer-heat effect.For turbi damp obstructing in middle-JIAO, the vomiting of gastral cavity ruffian, summer-heat and damp exterior syndrome, damp-warm syndrome is from the beginning of burnout of generating heat is uncomfortable in chest not relax, and cold-dampness closes heat, and stomachache is vomited and diarrhoea, nasosinusitis headache.Patchouli oil is its extract.
Oenothera biennis is also known as cordate telosma, screwtree root.It is sweet, bitter, it is warm-natured.Wind-damp dispelling, strengthening the bones and muscles.It is promoting blood circulation and removing obstruction in channels for soreness of bones and muscles；Suppressing the hyperactive liver to relieve the wind syndrome；Healing up sore and subduing swelling.Main chest impediment and cardialgia；Hemiplegia；Endogenous deficient wind；Children are more dynamic；Wind dampness rheumatic anesthesia pain；Stomachache diarrhea；Dysmenorrhoea；Fox is puzzled；Sore；Eczema.Evening primrose oil is its extract.
Embodiment
Describe fully to show specific embodiments of the present invention below, to enable those skilled in the art to put into practice them.The scope of embodiment of the present invention includes the gamut of claims.Herein, these embodiments of the invention individually or can be represented generally with term " invention ", and this is just for the sake of convenient.
Embodiment one
Take 5 parts of Chinese mugwort oil, 2 parts of cinnamon oil, 2 parts of patchouli oil, 2 parts of evening primrose oil；This moxibustion lung large intestine system channels and network vessels regulation essential oils will be obtained according to parts by weight are well mixed by four kinds of essential oils above.
In use, this appropriate moxibustion is taken at corresponding acupuncture point, to be coordinated manual massage with lung large intestine system channels and network vessels regulation essential oils, fully absorb it.
Moxibustion described in the present embodiment is tried out with lung large intestine system channels and network vessels regulation essential oils through experimental example, and it is moistening the lung and relieve the cough, and ensures significant effect in terms of smooth breathing.Specific experiment example is as follows：
（One）Diagnostic criteria
Tcm syndrome standard：Reference《New Chinese medicine guideline of clinical investigations》And《Practical clinical practice》, determine that the clinical manifestation of lung heat impairment of yin card is as follows：Cough, dry throat pharynx are itched, or cough battle array work of choking, cough are very then intended to vomit, trachyphonia, or it is uncomfortable in chest out of breath, cough is acute from the burst of the factor such as hot-air, peculiar smell or exacerbation to the cold, or sleeping morning at night, more in repeatability breaking-out, dry cough without phlegm or few phlegm, the red tongue of tongue is white or yellow, dries few Tianjin, wiry and rolling pulse or string are thin.
（Two）Packet
1st, inclusive criteria
Chinese medical discrimination is demonstrate,proved for lung heat impairment of yin；18~65 years old age.
2nd, Excluded cases standard
Serious respiratory disease, such as COPD, lung cancer, pulmonary tuberculosis.Age is more than 65 years old and less than 18 years old person.Gestation or women breast-feeding their children, or prepare the women of gestation.Mental patient, mismatch experimenter.
3rd, the standard compliant people of experimenter 90 is chosen, is divided into three groups of experimental group 1, experimental group 2 and control group, every group of each 30 people.
（Three）Experiment
Control group：Acupoint selection feishu, Zhongfu, Zusanli（Bilateral）, while impose moxa-moxibustion 20-40 minutes.
Experimental group 1：Acupoint selection feishu, Zhongfu, Zusanli (bilateral), appropriate the present embodiment essential oils are smeared at above-mentioned acupuncture point, after fully absorbing, is simultaneously imposed moxa-moxibustion 20-40 minutes to above-mentioned acupuncture point.
Experimental group 2：Acupoint selection feishu, Zhongfu, Zusanli (bilateral), smeared at above-mentioned acupuncture point in right amount by 5 parts of 2 parts of radix scutellariae essential oil, 2 parts of magnolia vine fruit oil, 2 parts of cassia twig oil, 12 parts of RADIX PAEONIAE ALBA essential oil, 2 parts of bighead atractylodes rhizome essential oil, 2 parts of Pogostemon cablin essential, Chinese mugwort oil essential oils prepared, after fully absorbing, is simultaneously imposed moxa-moxibustion 20-40 minutes to above-mentioned acupuncture point.
Experimental group 1, experimental group 2 and equal 1 times/day of control group, the course for the treatment of is 2 weeks, observes curative effect.
（Four）Efficacy evaluation
Cure:Clinical manifestation disappears or basic disappearance.
It is effective:Clinical manifestation is relieved.
Effectively:Clinical manifestation all take a favorable turn.
It is invalid:Clinical manifestation is not relieved.
Effective percentage=(one invalid number of cases of total number of cases)/total number of cases X100%
（Five）Efficacy result
| Group | Cure | It is effective | Effectively | It is invalid | It is efficient（%） |
| Control group | 1 | 15 | 4 | 10 | 66.67 |
| Experimental group 1 | 2 | 16 | 7 | 5 | 83.33 |
| Experimental group 2 | 1 | 16 | 6 | 7 | 76.67 |
Embodiment two
Take 4 parts of Chinese mugwort oil, 1 part of cinnamon oil, 1 part of patchouli oil, 1 part of evening primrose oil；This moxibustion lung large intestine system channels and network vessels regulation essential oils will be obtained according to parts by weight are well mixed by four kinds of essential oils above.
In use, this appropriate moxibustion is taken at corresponding acupuncture point, to be coordinated manual massage with lung large intestine system channels and network vessels regulation essential oils, fully absorb it.
Moxibustion described in the present embodiment is tried out with lung large intestine system channels and network vessels regulation essential oils through experimental example, and it is moistening the lung and relieve the cough, and ensures significant effect in terms of smooth breathing.Specific experiment example is as follows：
（One）Diagnostic criteria
Tcm syndrome standard：Reference《New Chinese medicine guideline of clinical investigations》And《Practical clinical practice》, determine that the clinical manifestation of lung heat impairment of yin card is as follows：Cough, dry throat pharynx are itched, or cough battle array work of choking, cough are very then intended to vomit, trachyphonia, or it is uncomfortable in chest out of breath, cough is acute from the burst of the factor such as hot-air, peculiar smell or exacerbation to the cold, or sleeping morning at night, more in repeatability breaking-out, dry cough without phlegm or few phlegm, the red tongue of tongue is white or yellow, dries few Tianjin, wiry and rolling pulse or string are thin.
（Two）Packet
1st, inclusive criteria
Chinese medical discrimination is demonstrate,proved for lung heat impairment of yin；18~65 years old age.
2nd, Excluded cases standard
Serious respiratory disease, such as COPD, lung cancer, pulmonary tuberculosis.Age is more than 65 years old and less than 18 years old person.Gestation or women breast-feeding their children, or prepare the women of gestation.Mental patient, mismatch experimenter.
3rd, the standard compliant people of experimenter 90 is chosen, is divided into three groups of experimental group 1, experimental group 2 and control group, every group of each 30 people.
（Three）Experiment
Control group：Acupoint selection feishu, Zhongfu, Zusanli（Bilateral）, while impose moxa-moxibustion 20-40 minutes.
Experimental group 1：Acupoint selection feishu, Zhongfu, Zusanli (bilateral), appropriate the present embodiment essential oils are smeared at above-mentioned acupuncture point, after fully absorbing, is simultaneously imposed moxa-moxibustion 20-40 minutes to above-mentioned acupuncture point.
Experimental group 2：Acupoint selection feishu, Zhongfu, Zusanli (bilateral), smeared at above-mentioned acupuncture point in right amount by 5 parts of 2 parts of radix scutellariae essential oil, 2 parts of magnolia vine fruit oil, 2 parts of cassia twig oil, 2 parts of RADIX PAEONIAE ALBA essential oil, 2 parts of bighead atractylodes rhizome essential oil, 2 parts of Pogostemon cablin essential, Chinese mugwort oil essential oils prepared, after fully absorbing, is simultaneously imposed moxa-moxibustion 20-40 minutes to above-mentioned acupuncture point.
Experimental group 1, experimental group 2 and equal 1 times/day of control group, the course for the treatment of is 2 weeks, observes curative effect.
（Four）Efficacy evaluation
Cure:Clinical manifestation disappears or basic disappearance:
It is effective:Clinical manifestation is relieved;
Effectively:Clinical manifestation all take a favorable turn;
It is invalid:Clinical manifestation is not relieved.
Effective percentage=(one invalid number of cases of total number of cases)/total number of cases X100%
（Five）Efficacy result
| Group | Cure | It is effective | Effectively | It is invalid | It is efficient（%） |
| Control group | 1 | 15 | 4 | 10 | 66.67 |
| Experimental group 1 | 2 | 15 | 7 | 6 | 80 |
| Experimental group 2 | 1 | 14 | 8 | 7 | 76.67 |
Embodiment three
Take 10 parts of Chinese mugwort oil, 5 parts of cinnamon oil, 5 parts of patchouli oil, 5 parts of evening primrose oil；This moxibustion lung large intestine system channels and network vessels regulation essential oils will be obtained according to parts by weight are well mixed by four kinds of essential oils above.
In use, this appropriate moxibustion is taken at corresponding acupuncture point, to be coordinated manual massage with lung large intestine system channels and network vessels regulation essential oils, fully absorb it.
Moxibustion described in the present embodiment is tested with lung large intestine system channels and network vessels regulation essential oils through experimental example, and it has a good result in gut purge defaecation in terms of excretion vivotoxin, and specific experiment result is as follows：
（One）Research object
Selection tcm diagnosis is the patient 90 of functional consitipation (deficiency of Yin intestinal dryness type), is ready to receive this experimenter, and observation case is randomly divided into 3 groups, wherein test group 1, experimental group 2 and each 30 of control group.
（Two）Research method
1st, diagnostic criteria
Tcm diagnosis standard (syndrome of intestine dryness due to yin deficiency):Reference《New Chinese medicine treats the guideline of clinical investigations of constipation》、《Traditional Chinese medical science Disease Diagnosis Standard》Relevant content formulate.
Primary symptom:Under dry and hard excrement difficulty, defecation frequency is reduced.
Secondary disease:1. defecation is not to the utmost, defecation is laborious, and defecation is not smooth, stomachache, abdominal distension discomfort;2. receive poor, mouth parched and tongue scorched, dysphoria in chestpalms-soles, oliguria with yellow urine.
Tongue picture:Tongue is red, few tongue.
Pulse condition:Thready rapid pulse.
Above primary symptom is indispensable, have both time disease 1., be diagnosable with reference to tongue vein 2. each more than 1 in item.
2nd, inclusive criteria
Patient diagnosed belongs to deficiency of Yin intestinal dryness type, and meets traditional Chinese medical science syndrome of intestine dryness due to yin deficiency disease diagnostic criteria;Age at entry 18-70 year.
3rd, exclusion standard
1. by enteron aisle organic disease, the constipation person as caused by rectum, colon organic disease (such as IBD, tumour, polyp of colon, intestinal tuberculosis etc.) caused by bowel narrow;Anus lesion causes dysporia person and the constipation person as caused by other whole body organic diseases or drug factors;
2. tumor in digestive tract or other involve gastral systemic disease, such as nervimuscular lesion, and the secondary constipation of the clear and definite cause of disease;
3. gestation and women breast-feeding their children;
4. allergic constitution or to composition allergy sufferers known to this medicine;
5. merge the severe primary diseases such as cardiovascular and cerebrovascular, liver, kidney, endocrine, nervous system and hemopoietic system, mental patient;
6. used within nearly 1 week treatment functional consitipation medicine person.
（Three）Test method
Control group：Big horizontal, CHENGSHAN acupoint is taken, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Experimental group 1：Big horizontal, CHENGSHAN acupoint is taken, appropriate the present embodiment essential oils are smeared above, after fully absorbing, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Experimental group 2：Big horizontal, CHENGSHAN acupoint is taken, is smeared above in right amount by 5 parts of 10 parts of Radix Codonopsis oil, 5 parts of Rhizoma Atractylodis Macrocephalae oil, 5 parts of Poria cocos oil, 10 parts of tuber of dwarf lilyturf oil, 5 parts of cinnamon oil and evening primrose oil essential oils modulated, after fully absorbing, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Above-mentioned 1 times/day of experiment, 7 days courses for the treatment of, totally 3 courses for the treatment of.Curative effect is observed after 3 courses for the treatment of.
（Four）Efficacy evaluation
Recovery from illness:Symptom disappears;
It is effective:Symptom improves percentage >=80%;
It is progressive:50%≤symptom improves percentage<80% ;
It is invalid:Symptom improves percentage<50%;
（Five）Experimental result
| Group | N | Recovery from illness | It is effective | It is progressive | It is invalid | Total effective rate % |
| Control group | 30 | 2 | 8 | 12 | 8 | 73.33 |
| Experimental group 1 | 30 | 4 | 12 | 12 | 2 | 93.33 |
| Experimental group 2 | 30 | 2 | 10 | 12 | 6 | 80 |
Note：Total effective rate=（N- invalid numbers）/NX100%
Experimental result is shown：
1. the total effective rate of experimental group 1 is 93.33%, the total effective rate of experimental group 2 is 80%, obviously higher than the 73.33% of control group.
2. the present embodiment essential oils have good gut purge defaecation, vivotoxin effect is drained.
Example IV
Take 5.5 parts of Chinese mugwort oil, 2.5 parts of cinnamon oil, 2.5 parts of patchouli oil, 2.5 parts of evening primrose oil；This moxibustion lung large intestine system channels and network vessels regulation essential oils will be obtained according to parts by weight are well mixed by four kinds of essential oils above.
In use, this appropriate moxibustion is taken at corresponding acupuncture point, to be coordinated manual massage with lung large intestine system channels and network vessels regulation essential oils, fully absorb it.
Moxibustion described in the present embodiment is tested with lung large intestine system channels and network vessels regulation essential oils through experimental example, and it has a good result in gut purge defaecation in terms of excretion vivotoxin, and specific experiment result is as follows：
（One）Research object
Selection tcm diagnosis is the patient 90 of functional consitipation (deficiency of Yin intestinal dryness type), is ready to receive this experimenter, and observation case is randomly divided into 3 groups, wherein test group 1, experimental group 2 and each 30 of control group.
（Two）Research method
1st, diagnostic criteria
Tcm diagnosis standard (syndrome of intestine dryness due to yin deficiency):Reference《New Chinese medicine treats the guideline of clinical investigations of constipation》、《Traditional Chinese medical science Disease Diagnosis Standard》Relevant content formulate.
Primary symptom:Under dry and hard excrement difficulty, defecation frequency is reduced.
Secondary disease:1. defecation is not to the utmost, defecation is laborious, and defecation is not smooth, stomachache, abdominal distension discomfort;2. receive poor, mouth parched and tongue scorched, dysphoria in chestpalms-soles, oliguria with yellow urine.
Tongue picture:Tongue is red, few tongue.
Pulse condition:Thready rapid pulse.
Above primary symptom is indispensable, have both time disease 1., be diagnosable with reference to tongue vein 2. each more than 1 in item.
2nd, inclusive criteria
Patient diagnosed belongs to deficiency of Yin intestinal dryness type, and meets traditional Chinese medical science syndrome of intestine dryness due to yin deficiency disease diagnostic criteria;Age at entry 18-70 year.
3rd, exclusion standard
1. by enteron aisle organic disease, the constipation person as caused by rectum, colon organic disease (such as IBD, tumour, polyp of colon, intestinal tuberculosis etc.) caused by bowel narrow;Anus lesion causes dysporia person and the constipation person as caused by other whole body organic diseases or drug factors;
2. tumor in digestive tract or other involve gastral systemic disease, such as nervimuscular lesion, and the secondary constipation of the clear and definite cause of disease;
3. gestation and women breast-feeding their children;
4. allergic constitution or to composition allergy sufferers known to this medicine;
5. merge the severe primary diseases such as cardiovascular and cerebrovascular, liver, kidney, endocrine, nervous system and hemopoietic system, mental patient;
6. used within nearly 1 week treatment functional consitipation medicine person.
（Three）Test method
Control group：Big horizontal, CHENGSHAN acupoint is taken, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Experimental group 1：Big horizontal, CHENGSHAN acupoint is taken, appropriate the present embodiment essential oils are smeared above, after fully absorbing, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Experimental group 2：Big horizontal, CHENGSHAN acupoint is taken, is smeared above in right amount by 5 parts of 10 parts of Radix Codonopsis oil, 5 parts of Rhizoma Atractylodis Macrocephalae oil, 5 parts of Poria cocos oil, 10 parts of tuber of dwarf lilyturf oil, 5 parts of cinnamon oil and evening primrose oil essential oils modulated, after fully absorbing, moxa-moxibustion is imposed 30 minutes to above-mentioned acupuncture point simultaneously.
Above-mentioned 1 times/day of experiment, 7 days courses for the treatment of, totally 3 courses for the treatment of.Curative effect is observed after 3 courses for the treatment of.
（Four）Efficacy evaluation
Recovery from illness:Symptom disappears;
It is effective:Symptom improves percentage >=80%;
It is progressive:50%≤symptom improves percentage<80% ;
It is invalid:Symptom improves percentage<50%;
（Five）Experimental result
| Group | N | Recovery from illness | It is effective | It is progressive | It is invalid | Total effective rate % |
| Control group | 30 | 2 | 8 | 12 | 8 | 73.33 |
| Experimental group 1 | 30 | 4 | 10 | 12 | 4 | 86.7 |
| Experimental group 2 | 30 | 2 | 10 | 12 | 6 | 80 |
Note：Total effective rate=（N- invalid numbers）/NX100%
It should also be appreciated by one skilled in the art that embodiment only represents possible change.The part of some embodiments and feature can be included in or replace part and the feature of other embodiments.
Claims (3)
1. a kind of moxibustion lung large intestine system channels and network vessels regulation essential oils, it is characterised in that be made up of the component of following parts by weight：
End oily 4-10 parts, cinnamon oil 1-5 parts, patchouli oil 1-5 parts, evening primrose oil 1-5 parts.
2. moxibustion according to claim 1 lung large intestine system channels and network vessels regulation essential oils, it is characterised in that be made up of the component of following parts by weight：
End oily 5-9 parts, cinnamon oil 2-4 parts, patchouli oil 2-4 parts, evening primrose oil 2-4 parts.
3. moxibustion according to claim 1 lung large intestine system channels and network vessels regulation essential oils, it is characterised in that be made up of the component of following parts by weight：
5 parts of Chinese mugwort oil, 3 parts of cinnamon oil, 3 parts of patchouli oil, 3 parts of evening primrose oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610319192.1A CN107375426A (en) | 2016-05-16 | 2016-05-16 | A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610319192.1A CN107375426A (en) | 2016-05-16 | 2016-05-16 | A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107375426A true CN107375426A (en) | 2017-11-24 |
Family
ID=60338679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610319192.1A Pending CN107375426A (en) | 2016-05-16 | 2016-05-16 | A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107375426A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972642A (en) * | 2021-02-23 | 2021-06-18 | 浙江纤码健康管理有限公司 | Intestine moistening plant extract oil and preparation process thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666494A (en) * | 2014-10-31 | 2015-06-03 | 普正药业股份有限公司 | Eucommia ulmoides moxibustion product and preparation method thereof |
| CN204910078U (en) * | 2015-07-07 | 2015-12-30 | 武汉艾益家科技有限公司 | Essential oil paster for moxibustion treatment |
-
2016
- 2016-05-16 CN CN201610319192.1A patent/CN107375426A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666494A (en) * | 2014-10-31 | 2015-06-03 | 普正药业股份有限公司 | Eucommia ulmoides moxibustion product and preparation method thereof |
| CN204910078U (en) * | 2015-07-07 | 2015-12-30 | 武汉艾益家科技有限公司 | Essential oil paster for moxibustion treatment |
Non-Patent Citations (5)
| Title |
|---|
| IAIR艾阿精油: "艾草精油-人体清道夫", 《HTTPS://WEIBO.COM/P/1001603784095393012910》 * |
| JJ281329194: "四季养生短信 艾灸信息", 《HTTPS://WENKU.BAIDU.COM/VIEW/39AFF19D910EF12D2AF9E794.HTML#》 * |
| 柳春玲: "敷脐疗法治疗小儿脾虚泄泻23例", 《甘肃中医学院学报》 * |
| 欧阳忠兴，等: "《中医呼吸病学》", 31 May 1994, 北京：中国医药科技出版社 * |
| 高学敏: "《中药学》", 28 February 2003, 中国中医药出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972642A (en) * | 2021-02-23 | 2021-06-18 | 浙江纤码健康管理有限公司 | Intestine moistening plant extract oil and preparation process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547685A (en) | Traditional Chinese medicine preparation for treating kidney stone and urinary stone | |
| CN105106588A (en) | Traditional Chinese medicinal composition for effectively treating constipation | |
| CN103860896B (en) | A kind of medicine for the treatment of chronic obstructive emphysema | |
| CN106362111A (en) | Pharmaceutical composition for improving phlegm-dampness constitution, medicine brick and preparation method of medicine brick | |
| CN102846770A (en) | Pure traditional Chinese medicine capsules for treating constipation | |
| CN110302332A (en) | A kind of Chinese medicine composition and preparation method thereof for treating intestinal cancer | |
| CN107375426A (en) | A kind of moxibustion lung large intestine system channels and network vessels regulation essential oils | |
| CN101700391B (en) | Oral traditional Chinese medicine composition for treating psoriasis | |
| CN103212026B (en) | A kind of Chinese medicine for the treatment of cholelithiasis and preparation method thereof and instructions of taking | |
| CN105477551A (en) | Formula of traditional Chinese medicine for treating ovarian cyst | |
| CN104998074A (en) | Traditional Chinese medicine for treating gastropathy and preparation method thereof | |
| CN104606489A (en) | Traditional Chinese medicine formula for treating ovarian cyst | |
| CN107375597A (en) | A kind of moxibustion motive small intestine system channels and network vessels regulation essential oils | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN103893666B (en) | A kind of medicine for the treatment of chronic bronchitis | |
| CN109010779A (en) | A kind of traditional Chinese medicine lotion and its application method for treating hemorrhoid | |
| CN103330820A (en) | Chinese medicinal composition for auxiliary treatment of sepsis | |
| CN102552784B (en) | Preparation method of traditional Chinese medicine for treating prostatitis caused by fire excess from yin deficiency | |
| CN105687656A (en) | Pharmaceutical composition for treating myelitis and preparation method thereof | |
| CN104740200A (en) | Traditional Chinese medicine spray for treating nasal obstruction caused by chronic nasosinusitis and preparation method of traditional Chinese medicine spray | |
| CN106110193A (en) | A kind of external skin ulcer convergence ointment and compound method thereof | |
| CN105194588A (en) | Traditional Chinese medicine preparation for treating liver cirrhosis | |
| CN105343298A (en) | Navel patch for treating chronic constipation and preparation method thereof | |
| CN104474210A (en) | Traditional Chinese medicine composition for treating unstable angina pectoris caused by qi stagnation and blood stasis | |
| CN104825883A (en) | Traditional Chinese medicine prescription for treating rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171124 |
|
| RJ01 | Rejection of invention patent application after publication |